← Leaderboards
Yoshitomo Hamuro
Exsar Corporation
$407,382
Attributed
$407,382
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $174.3K · FY2006–08$200K$150K$100K$50K$0
'06
'07
'08
Funding mix
By agency
NIH$407,382 · 2
By mechanism
R43$407,382 · 2
Top collaborators
No co-investigators on record.
Most similar at Exsar Corporation
Same institution · by research overlap
- Patrick Robert Griffin$27,944,167
Others in their field
Top investigators on “Pharmacologic Substance”
- David Heimbrook · Leidos Biomedical Research, Inc.$127,683,054
- Myron S Cohen · Family Health International$104,232,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$104,068,526
- Garret A Fitzgerald · University Of Pennsylvania$73,814,804
- James Dennis Neaton · Northwestern University$65,107,995
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$53,206,876
Research focus
Pharmacologic SubstanceReactionInstrumentationMiniaturizeProtein DynamicsProteolysisEnd PointInstrumentLigandsMeasurementBasic ScienceAmidesProtein Protein InteractionProteinsBiotechnologyDeuteriumEquipmentHydrogenAutomationLaboratoriesMapsConditionCoupledResolution